Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · IEX Real-Time Price · USD
4.260
-0.130 (-2.96%)
At close: Jul 19, 2024, 4:00 PM
4.250
-0.010 (-0.23%)
Pre-market: Jul 22, 2024, 6:13 AM EDT
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $260.50 million as of July 22, 2024. Its market cap has decreased by -16.67% in one year.
Market Cap
260.50M
Enterprise Value
107.93M
1-Year Change
-16.67%
Ranking
Category
Stock Price
$4.26
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has decreased from $845.31M to $260.50M, a decrease of -69.18%. That is a compound annual growth rate of -31.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 215.20M | -23.96% |
| Dec 29, 2023 | 283.00M | -23.16% |
| Dec 30, 2022 | 368.30M | -61.22% |
| Dec 31, 2021 | 949.70M | 12.35% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Auna SA | 266.70M |
| Tenaya Therapeutics | 266.17M |
| Viemed Healthcare | 264.37M |
| Zentalis Pharmaceuticals | 262.75M |
| Inovio Pharmaceuticals | 260.92M |
| Sanara MedTech | 260.05M |
| MultiPlan | 257.95M |
| Nektar Therapeutics | 255.79M |